Foresight intelligence on the innovations and Trends shaping the future of health, wellness, and fitness

Powered by our proprietary AI Foresight Intelligence System and signal analysis. 

Foreisght Intelligence System

Join Business leaders, Founders, Investors, Innovators, Marketers and Practitioners

Brand logos

The future of health, wellness, and fitness is being rewritten in real time.

The pace of change is fast. Every week, 1000’s of signals provide new information and data about new technologies, new products, new capabilities and new claims about what’s next. 

But more information hasn’t made decision-making easier. It’s made it harder.

  • What is real vs. hype?
  • Which innovations will actually scale?
  • How fast will markets shift?
  • Where should you act now?

 

Most platforms give you information.
Few give you clarity.

The future is often buried in noise. Our Foresight System filters the noise into structured intelligence.

Elevate Ninety transforms fragmented signals into structured foresight.

We don’t just surface what innovations and trends are emerging, we quantify its potential, track its trajectory and connect it to real-world decisions.

So instead of reacting to change, you can anticipate it.

Foreisght Intelligence System

AI Powered System Built for Decision Making

Elevate Ninety is built on a dual intelligence model:

AI-powered detection + human foresight analysis. We turn raw signals and information into decision making intelligence.

A foresight intelligence system built for decision makers and innovators in  health, wellness and fitness.

1. AI Signal Detection
We continuously scan thousands of signals across scientific research, clinical validation, product launches, patents, funding, mergers & acquisitions, behavioural shifts.

2. Foresight Index Scoring
Each innovation is evaluated based on our 5 foresight factors that scores its real-world impact potential and readiness for mainstream adoption.

3. Continuous Tracking
Combing AI and human analysis, we monitor how innovations and trends evolve, identifying acceleration, inflection points, and market shifts.

4. Decision Making Tools
We provide various tools such as dashboards, real-time content, reports and AI assistants to ensure users have strategic answers at their finger tips.

The Pulse Delivers Signals and Foresight Every Week

Sign up to our newsletter, The Pulse to receive weekly foresight and signals that give you clearer understanding of the future in health, wellness and fitness

Latest Signals

Nu Skin launches Prysm iO, an AI-powered nutritional wellness platform that gives a 15-second carotenoid-based “Nutrition Health Score” and ties into its supplement ecosystem

Consumer nutrition is shifting toward closed-loop, data-driven systems, with Nu Skin’s Prysm iO signalling the emergence of real-time diagnostics integrated directly into personalised supplement ecosystems. This is an early signal of nutrition evolving into a measurable, feedback-driven infrastructure rather than a static product category.

Digital Health & Fitness, Nutrition
Infrastructure, Product / Platform
Free

Enbiosis reveals 2.0, an AI-powered digital-twin platform for fast creation of clinically credible gut-health formulations

AI-powered digital twins are entering nutrition formulation, enabling rapid, microbiome-driven product design with clinical grounding. As highlighted by Enbiosis 2.0, this is an early signal of a shift from product-led innovation to infrastructure-led formulation systems.

Digital Health & Fitness, Medical & Pharma, Nutrition
New Evidence, Product / Platform
Free

eMed’s $200M Raise Signals the Rise of AI Orchestrated GLP-1 Care

eMed’s (backed by Tom Brady) raise is an early signal that investor conviction is moving toward the service and orchestration layer around GLP 1s, especially where AI, employer benefits, clinical support, and at home care delivery converge. The supporting signal is the company’s explicit plan to use the capital to expand agentic AI and fund employer models tied to ongoing GLP 1 access and support.

Digital Health & Fitness, Medical & Pharma
Funding, M&A
Free

Cardio-metabolic Prevention is Shifting from Late-Stage Management to Early, Precision Intervention

A series of recent clinical studies across hypertension, lipid management, and biomarker research signal a coordinated shift toward earlier, more precise cardiometabolic prevention, where intervention is driven by underlying biology and risk stratification rather than late-stage disease presentation.

Medical & Pharma
Behavioural, New Evidence
Core